ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1510	National Cancer Institute	Html	en	Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of small cell lung cancer.	Lung Cancer Cooperative 0.39126 small-cell lung cancer 0.985475 European Lung Cancer 0.390681 chemotherapy 0.385408 Engl J Med 0.425383 American Cancer Society 0.349857 Br J Cancer 0.382857 limited-stage small-cell lung 0.52446 Lung cancer deaths 0.390773 tobacco-specific lung carcinogen 0.37583 Lung Oncology Group 0.359221 Radiat Oncol Biol 0.383871 Lung Cancer Group 0.384497 oncology group study 0.36864 poor-prognosis small-cell lung 0.365771 Natl Cancer Inst 0.372388 cancer research campaign 0.352725 Council Lung Cancer 0.415558 stage small-cell lung 0.379153 Medical Research Council 0.386248 small-cell lung carcinoma 0.374311 et al. 0.448513 Lung Cancer Working 0.375734 extensive-disease small-cell lung 0.370168 Research Council Lung 0.400238	Cancer Epidemiol Biomarkers 0.349186 PUBMED Abstract 0.373095 limited-disease small-cell lung 0.382414 extensive small-cell lung 0.411565 limited-stage small cell 0.350265 small cell lung 0.655538 prophylactic cranial irradiation 0.394396 disease small-cell lung 0.396424 extensive-stage small-cell lung 0.398504 lung cancer patients 0.41432 Cancer Lung Cancer 0.412017 Abstract 0.488813 Clin Oncol 0.605439 cell lung carcinoma 0.379947 Oncol Biol Phys 0.385351 untreated small-cell lung 0.364584 lung cancer risk 0.385828 advanced small-cell lung 0.364607 Low-dose lung 0.356029 cell lung cancer 0.62237 better-prognosis small-cell lung 0.365507 multiple lung nodules 0.359952 thoracic radiotherapy 0.411609 limited small-cell lung 0.423802	CLICK HERE
1529	National Cancer Institute	Html	en	Male Breast Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of male breast cancer.	Clinical breast exam 0.284327 Breast Cancer Screening 0.314882 breast duct 0.265624 cancer spreads 0.259464 diagnose breast cancer 0.343362 malignant tumor cells 0.26356 body 0.314871 PDQ cancer information 0.299069 Inflammatory Male Breast 0.288019 clinical trials 0.336788 breast cancer stage 0.313107 cancer information summary 0.28338 clinical trial 0.259026 breast cancer prevention 0.329746 breast cancer patients 0.302243 lymph node biopsy 0.306018 sentinel lymph node 0.33726 Inflammatory breast cancer 0.359802 NCI PDQ cancer 0.260729 early localized breast 0.2726 lymph nodes 0.375271 breast carcinoma 0.267321 metastatic breast cancer 0.413709 radiation therapy 0.324944 treatment 0.354882	abnormal cells 0.280815 male breast cancer 0.548303 cancer cells 0.507692 Cancer Information Service 0.257721 specific cancer cells 0.266994 breast cancers 0.260852 National Cancer Institute 0.306996 Breast Cancer Treatment 0.32856 hormone therapy 0.286562 painful breast lesions 0.269444 lymph vessels 0.259581 new treatment 0.256083 breast cancer cells 0.328644 breast cancer 0.95341 Hereditary breast cancer 0.321208 chest wall 0.263619 Recurrent breast cancer 0.304665 IIIC breast cancer 0.305672 tumor 0.317659 treatment options 0.26574 cancer information summaries 0.256227 comprehensive cancer information 0.256173 information 0.313083 appropriate cancer treatment 0.261896	CLICK HERE
1703	National Cancer Institute	Html	en	Tumor Grade	A fact sheet that discusses tumor grade and its role in prognosis. Explains concepts like normal cell biology and cell differentiation.	Gleason score 0.401724 NCI fact sheet 0.404685 lower grade 0.405507 tissue organization 0.400496 better prognosis 0.354968 tumor tissue 0.703634 type-specific grading systems 0.412132 tumor type 0.491464 cancer cells 0.405656 biopsied tissue 0.413701 Gleason scores 0.355221 primary brain tumors 0.42294 tumor size 0.501863 abnormal-looking cells 0.400459 Nottingham grading 0.360235 higher-grade cancer 0.364598 tumor cells 0.631844 normal cells 0.49423 nearby lymph nodes 0.408457 tumor grade 0.785451 regional lymph node 0.409603 secondary pattern 0.388809 breast tumors 0.384185 Scarff-Bloom-Richardson grading 0.361738	normal tissue structures 0.487646 primary pattern 0.353415 microscopic examination 0.353649 breast cancer 0.39308 biopsy samples 0.354483 Staging page 0.357155 microscopic appearance 0.359178 different types 0.358151 tumors 0.490957 prostate cancer 0.440387 cancer staging 0.368981 slower rate 0.360886 American Joint Committee 0.39399 tumor 0.981653 tumor grades 0.501473 common tissue pattern 0.44497 cancer 0.557882 total score 0.354108 soft tissue sarcoma 0.443518 prostate cancers 0.367392 Gleason scoring 0.35738 tumor tissue look 0.635152 cancer stage 0.457333	CLICK HERE
1751	National Cancer Institute	Html	en	Hospice Care	A fact sheet about hospice care, including insurance coverage.	palliative care share 0.4463 home health 0.436046 hospice programs 0.663338 hospice team 0.740949 specific care decisions 0.42786 hospice doctor 0.624846 spiritual support 0.408056 public health departments 0.391127 American Cancer Society 0.455655 hospice services 0.722561 home health aides 0.405139 state Medicaid office 0.402126 nursing care 0.391635 hospice medical director 0.768439 Hospice Association 0.649826 cancer care 0.409838 hospital business office 0.388593 life expectancy 0.408587 hospice team member 0.685192 special in-patient facilities 0.500987 Medicare website 0.415518 specific state locations 0.392604 government health insurance 0.402081 sheet Palliative Care 0.444628 state social services 0.40519	nursing homes 0.407681 end-of-life care 0.424373 health aide services 0.410795 hospice organizations 0.592662 Palliative Care Organization 0.507564 private insurance plans 0.399019 Hospice Net 0.623257 palliative care 0.604188 Medicare coverage 0.386456 national hospice 0.673933 regional home health 0.398589 national hospice programs 0.634262 hospice care 0.982488 local state welfare 0.391739 health insurance plans 0.419219 Medicare benefits 0.388255 hospice expenses 0.700651 insurance plans 0.503978 federal-state partnership program 0.389089 Medicare Hospice Benefits 0.695621 Medicare-certified hospice programs 0.660409 Respite Care page 0.429976 social work services 0.407475 free fact sheets 0.38648	CLICK HERE
1806	National Cancer Institute	Html	es	Tratamiento del cáncer de estómago (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de estómago.	after d2 gastrectomy 0.313513 gastrectomía d2 0.31496 Cunningham D 0.34388 Macdonald JS 0.318723 Chemoradiotherapy after surgery 0.344328 randomised controlled 0.319618 combined modality therapy 0.360634 mejoría significativa 0.31176 Stenning SP 0.310838 intergroup trial calgb 0.31542 Postoperative adjuvant chemoradiation 0.322032 after ci 5-fu 0.317294 fase iii 0.364462 Estados Unidos 0.347269 with s-1 0.314235 randomized trial comparing 0.314288 quimiorradioterapia posoperatoria 0.360835 ensayo rtog-9904 0.324678 patients with 0.484752 adyuvante versus tasa 0.360686 supportive care 0.325372 Clinical Oncology 0.311085 Perioperative chemotherapy versus 0.334581 chemotherapy plus best 0.312401 Smalley SR 0.318682	with surgery 0.339493 Ajani JA 0.354002 or gastroesophageal junction 0.340588 ensayo swog-s0425 0.324881 Allum WH 0.311046 quimiorradioterapia adyuvante versus 0.364135 estadio ib 0.338006 gastrectomía curativa d2 0.319296 Van Cutsem E 0.313883 Benedetti J 0.318647 quimioterapia perioperatoria 0.352185 gastric carcinoma 0.325701 gastric cancer 0.935626 Clin Oncol 0.612714 or gastro-oesophageal junction 0.317111 trial comparing 0.314461 supportive care with 0.324232 Winter K 0.319459 Gastric Cancer Study 0.317632 chemotherapy versus surgery 0.338116 grupo s-1 0.317965 Okawara GS 0.319919 care with best 0.314996 quimioterapia posoperatoria 0.31518	CLICK HERE
1943	National Cancer Institute	Html	es	Síndromes cardiopulmonares (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca de las afecciones comunes que producen síntomas en el tórax. Los síndromes cardiopulmonares que se exponen en este sumario son la disnea relacionada con el cáncer, el derrame pleural maligno, el derrame pericárdico y el síndrome de la vena cava superior.	pleural catheter 0.17861 Ripamonti C 0.130559 dificultad respiratoria 0.26023 malignant effusion 0.115362 lung cancer 0.190962 Sin embargo 0.114284 end-of-life patients with 0.119385 indwelling pleural catheter 0.162022 Dudgeon DJ 0.13043 fármacos pleurales esclerosantes 0.112004 disfunción muscular respiratoria 0.121219 Hematol Oncol Clin 0.143013 hypoxemic patients with 0.118489 patients receiving chemotherapy 0.111162 Cancer Organisation Thoracic 0.117844 antitusivos opioides 0.112496 recurrent symptomatic malignant 0.110714 patients with 0.625852 insuficiencia cardiaca 0.134239 Pain Symptom Manage 0.478956 randomized controlled 0.112081 pleural fluid 0.136904 Cancer Dyspnea Scale 0.146703 Moroni M 0.110841 Care Cancer 0.128094	pleural catheter vs 0.135869 Physiol Neurobiol 0.116436 as symptomatic treatment 0.110943 derrame maligno fracasa 0.114534 obstructiva crónica 0.135859 vías respiratorias 0.205286 tunnelled pleural catheter 0.139919 tos crónica causa 0.111919 prospective randomized 0.110614 pleural effusions with 0.149859 Intern Med 0.132242 Clin Oncol 0.11762 Med Pediatr Oncol 0.111608 Clin North Am 0.136363 Bruera E 0.203018 systematic review 0.116364 Oncol Clin North 0.140711 American Thoracic Society 0.114142 as palliative treatment 0.110799 malignant pleural effusions 0.900896 Crit Care Med 0.171232 symptomatic malignant 0.122652 alone versus 0.11566 compared with 0.110951	CLICK HERE
2082	National Cancer Institute	Html	en	Cancer Clusters	A fact sheet that describes what constitutes a cancer cluster and the process for reporting and investigating suspected clusters.	major risk factor 0.385962 specific environmental hazards 0.38074 rare cancer 0.409989 website uses data 0.380594 cancer trends 0.398646 individual cancer clusters 0.469731 number 0.405815 investigators 0.393508 Health Hazard Evaluation 0.380995 Disease Control 0.519415 Health Consultations page 0.381331 cancer cluster 0.895701 cancer clusters 0.841764 National Center 0.381056 ATSDR regional offices 0.380684 different geographic area 0.38274 cluster investigations 0.411002 true cancer clusters 0.482566 public health assessments 0.472612 statistically significant difference 0.384068 vinyl chloride 0.380035 specific cancer type 0.434002 primary cancer 0.413707 U.S. Census Bureau 0.37492 specific hazardous substances 0.37613	different cancer types 0.429181 state health department 0.450442 total number 0.385248 cancer cases 0.749447 health departments 0.457783 NCI analyze variations 0.380726 local health departments 0.450682 geographic area 0.518161 specific geographic area 0.389344 health surveillance programs 0.382617 people 0.378106 epidemiologic study 0.378396 agency gathers information 0.381997 statistically significant excess 0.455543 secondary cancer 0.393665 cancer 0.954313 state cancer registries 0.443891 cancer cluster—that 0.391887 Disease Registry 0.381886 specific time period 0.392616 Toxic Substances 0.380998 cancer death rates 0.436653 cancer incidence 0.401099 Cancer Mortality Maps 0.435229	CLICK HERE
3448	National Cancer Institute	Html	es	Prevención del cáncer de ano (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que pueden influir en el riesgo de presentar cáncer de ano, y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	Malignancies Among Cancer 0.376997 long-term risk 0.317273 lesiones precursoras 0.331467 Goldstone S 0.318721 American Cancer Society 0.336812 NIH Pub 0.338006 Giuliano AR 0.319633 CA Cancer 0.335938 Engels EA 0.334211 nationwide cohort study 0.318123 Second cancers among 0.32229 new malignancies 0.372644 Frisch M 0.318875 anal hpv 0.38502 Ron E 0.319704 risk factors 0.340585 anal intraepithelial neoplasia 0.348272 Natl Cancer Inst 0.37761 papillomavirus-related gynecologic neoplasm 0.319719 cancers among 0.324258 human papillomavirus 0.471776 Anal carcinoma 0.320142 Cancer Epidemiology 0.319322 hpv infection 0.344517 SEER Cancer Statistics 0.322144	have sex with 0.39684 cohort study 0.328375 who have sex 0.393593 anal intra-epithelial neoplasia 0.321943 Fraumeni JF Jr 0.315722 Madeleine MM 0.330833 SEER Cancer 0.386157 SEER Cancer Registries 0.37953 Infect Dis 0.350074 Cancer Facts 0.318636 Curtis RE 0.320735 New Malignancies Among 0.340351 National Cancer Institute 0.584605 among men 0.315549 características histológicas 0.334238 Among Cancer Survivors 0.378869 papillomavirus-associated anal cancers 0.323075 Palefsky JM 0.334575 Freedman DM 0.321699 Cancer Survival Among 0.320203 anal cancer 0.954929 New malignancies following 0.338599 sexual practices 0.336294 cuello uterino 0.534342	CLICK HERE
16162	National Cancer Institute	Html	en	New Therapies Are Changing the Outlook for Advanced Melanoma	An article about a host of new treatment options that have been produced in the last several years for patients with the skin cancer melanoma.	improved progression-free survival 0.366558 new therapies 0.351845 target BRAF proteins 0.357172 commonly used therapies 0.342946 BRAF inhibitor 0.43187 BRAF mutations 0.802264 Cancer Therapy Evaluation 0.357896 Overall survival results 0.381093 Dr. Schuchter 0.658164 overall survival 0.53856 clinical trials 0.561097 results 0.412771 median progression-free survival 0.364224 clinical trial 0.629151 median overall survival 0.359384 patients 0.941423 recent FDA-approved drugs 0.349384 tumor responses 0.376799 metastatic melanoma 0.378989 chemotherapy drug dacarbazine 0.34213 median survival 0.400006 melanoma specialist 0.389264 large clinical trial 0.469476 MEK inhibitor 0.413513	cancer cells 0.348742 Patient tumor samples 0.353483 skin-related side effects 0.386676 MEK inhibitor cobimetinib 0.40543 clinical trial participants 0.357541 BRAF-MEK inhibitor combination 0.3755 Dr. Streicher 0.487979 tumor cells 0.429743 checkpoint inhibitor 0.371337 small clinical trials 0.342687 drugs 0.41439 progression-free survival 0.707667 MEK inhibitors 0.605005 advanced melanoma 0.87481 PD-1 inhibitor 0.342866 recent clinical trials 0.345485 new treatment options 0.457424 tumors 0.426135 New Melanoma Therapies 0.48664 early-phase clinical trial 0.367414 Moffitt Cancer Center 0.358773 regulatory approval 0.407964 Pennsylvania Abramson Cancer 0.343564 skin cancer melanoma 0.49678	CLICK HERE
17279	National Cancer Institute	Html	es	Planes para atender un cáncer avanzado	Una planificación cuidadosa reducirá el peso que enfrentará su familia más adelante. La planificación puede incluir aspectos económicos y legales, pero como verá, también puede ser una forma de celebrar su vida y de darle significado.	tensiones. Algunas personas 0.876955		CLICK HERE